Cyberonics Advertisement Brought To FDA’s Attention By Public Citizen
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Device Evaluation is looking into a consumer-directed advertisement for Cyberonics' VNS Therapy device for treatment-resistant depression